Difference between revisions of "DallasWorkshop"

From NCBO Wiki
Jump to navigation Jump to search
 
(37 intermediate revisions by 2 users not shown)
Line 38: Line 38:
 
==Overview==
 
==Overview==
  
The aims of clinical and translational research are to achieve a better understanding of the pathogenesis of human disease in order to develop effective diagnostic, therapeutic and prevention strategies. Biomedical informatics can play an important role is supporting this research by facilitating the management, integration, analysis and exchange of data derived from and related to the research problems being studied. A key aspect of this support is to bring clarity, rigor and formalism to the representation of  
+
The aims of clinical and translational research are to achieve a better understanding of the pathogenesis of human disease in order to develop effective diagnostic, therapeutic and prevention strategies. Biomedical informatics can play an important role in supporting this research by facilitating the management, integration, analysis and exchange of data derived from and related to the research problems being studied. A key aspect of this support is to bring clarity, rigor and formalism to the representation of  
  
 
::1. disease initiation, progression, pathogenesis, signs, symptoms, assessments, clinical and laboratory findings, disease diagnosis, treatment, treatment response and outcome, and  
 
::1. disease initiation, progression, pathogenesis, signs, symptoms, assessments, clinical and laboratory findings, disease diagnosis, treatment, treatment response and outcome, and  
Line 62: Line 62:
 
==Agenda==
 
==Agenda==
  
'''Day 1: Wednesday, September 3''' (Room: Irving 2 & 3)
+
'''Day 1: Wednesday, September 3''' (Room: Irving I-III, Lobby Level)
  
 
8:30am - Registration and Continental Breakfast
 
8:30am - Registration and Continental Breakfast
Line 70: Line 70:
 
9:15am - Session 1: Signs, symptoms and laboratory findings from a health care perspective (Scheuermann, moderator)
 
9:15am - Session 1: Signs, symptoms and laboratory findings from a health care perspective (Scheuermann, moderator)
  
::: Combining clinical exam and laboratory findings in the rheumatology clinic [slides http://ontology.buffalo.edu/08/phenotype/karp.ppt](David Karp)
+
::: Combining clinical exam and laboratory findings in the rheumatology clinic [http://ontology.buffalo.edu/08/phenotype/karp.ppt slides] (David Karp)
::: Clinical signs and findings in neonatology (Andrew James)
+
::: Clinical signs and findings in neonatology [http://ontology.buffalo.edu/08/phenotype/JAMES.ppt slides] (Andrew James)
  
 
10:30am - Refreshment Break
 
10:30am - Refreshment Break
  
10:45am - Session 2: Ontology approaches to describing the clinical phenotype (Smith, moderator)
+
10:45am - Session 2: Ontology approaches to describing the clinical phenotype [http://ontology.buffalo.edu/08/phenotype/SMITH.ppt slides] (Smith, moderator)
  
::: Reasoning with clinical exam and laboratory findings: The case of myocardial infarction (Sivaram Arabandi)
+
::: Reasoning with clinical exam and laboratory findings: The case of myocardial infarction [http://ontology.buffalo.edu/08/phenotype/ARABANDI.pdf slides] (Sivaram Arabandi)
  
12:00pm - Buffet Lunch (Grand Prairie Room), '''''Provided by the generous support of''''' [http://www.leadhorsetech.com/LEAD_HORSE_TECHNOLOGIES/Home.html '''''Lead Horse Technologies, Inc.''''']
+
12:00pm - Buffet Lunch (Arlington Room, Lower Level), '''''Provided by the generous support of''''' [http://www.leadhorsetech.com/LEAD_HORSE_TECHNOLOGIES/Home.html '''''Lead Horse Technologies, Inc.''''']
  
1:00pm - Session 3: Standardization of clinical and laboratory data in the context of clinical and translational research (Ruttenberg, moderator)
+
1:00pm - Session 3: Standardization of clinical and laboratory data in the context of clinical and translational research (Jaffe, moderator)
  
::: Data standards from patient care to clinical and translational research: The CTSA perspective (Chris Chute)
+
::: Data standards from patient care to clinical and translational research: The CTSA perspective [http://ontology.buffalo.edu/08/phenotype/CHUTE.ppt slides] (Chris Chute)
::: Representation of clinical and laboratory findings in the CDISC SDTM (Bron Kisler)
+
::: Representation of clinical and laboratory findings in the CDISC SDTM [http://ontology.buffalo.edu/08/phenotype/KISLER-WALKER.ppt slides] (Bron Kisler and Gary Walker)
  
 
3:00pm - Refreshment Break
 
3:00pm - Refreshment Break
  
3:30pm - Session 3 continued
+
3:30pm - Session 3 continued (Ruttenberg, moderator)
  
::: The future of SNOMED-CT in the representation of clinical findings (Kent Spackman)
+
::: The future of SNOMED-CT in the representation of clinical findings [http://ontology.buffalo.edu/08/phenotype/SPACKMAN.ppt slides] (Kent Spackman)
:::       Problems with current approaches to clinical data (William Hogan)
+
:::     Problems with current approaches to clinical data [http://ontology.buffalo.edu/08/phenotype/HOGAN.ppt slides] (William Hogan)
  
5:30pm - Reception (Salons G & H), '''''Provided by the generous support of The Cleveland Clinic Foundation SemanticDB'''''
+
5:30pm - Reception (Grand Prairie Room, Lower Level), '''''Provided by the generous support of The Cleveland Clinic Foundation SemanticDB'''''
  
'''Day 2: Thursday, September 4''' (Room: Irving 2 & 3)
+
 
 +
'''Day 2: Thursday, September 4''' (Room: Irving I-III, Lobby Level)
  
 
8:30am - Continental Breakfast
 
8:30am - Continental Breakfast
  
9:00am - Session 4: Proposals for unification of standard terminologies for the representation ‘sign’, ‘symptom’, ‘finding’ and related terms (Bodenreider, moderator)
+
9:00am - Session 4: Proposals for unification of standard terminologies for the representation ‘sign’, ‘symptom’, ‘finding’ and related terms (Lewis, moderator)
  
::: Laboratory data and metadata in laboratory information systems (Olivier Bodenreider and Anita Burgun)  
+
::: Laboratory data and metadata in laboratory information systems [http://ontology.buffalo.edu/08/phenotype/BURGUN.ppt slides] (Anita Burgun)  
::: An ontology-based approach for connecting disease pathogenesis with clinical/laboratory data (Richard Scheuermann)
+
::: An ontology-based approach for connecting disease pathogenesis with clinical/laboratory data [http://ontology.buffalo.edu/08/phenotype/SCHEUERMANN.ppt slides] (Richard Scheuermann)
  
 
10:30am - Refreshment Break
 
10:30am - Refreshment Break
  
 
10:45am - Session 5: How consistent ontological design and development principles can lead to enhanced representation of signs, symptoms, and clinical and laboratory finding (Smith, moderator)
 
10:45am - Session 5: How consistent ontological design and development principles can lead to enhanced representation of signs, symptoms, and clinical and laboratory finding (Smith, moderator)
:::    PATO and Phenote: From model organism phenotypes to clinical medicine (Suzanna Lewis)
+
:::    PATO and Phenote: From model organism phenotypes to clinical medicine [http://ontology.buffalo.edu/08/phenotype/LEWIS.ppt slides] (Suzanna Lewis)
  
 
12:00pm - Lunch Break
 
12:00pm - Lunch Break
Line 119: Line 120:
 
4:00pm - Close
 
4:00pm - Close
  
==Confirmed Participants==
+
==Summary of Workshop==
 +
 
 +
* Summary [http://esw.w3.org/topic/HCLSIG/Meetings/2008-10-02_Conference_Call?action=AttachFile&do=get&target=NCBO_clinical_phenotype_ont.pdf slides] (Kei Cheung)
 +
 
 +
==Participants==
  
This is a working meeting and participation is restricted.  
+
[[image:photo.jpg|thumb|right]]
  
 
*Jonas Silva Almeida (MD Anderson Cancer Center / University of Texas)
 
*Jonas Silva Almeida (MD Anderson Cancer Center / University of Texas)
Line 128: Line 133:
 
*Robert Arp (National Center for Biomedical Ontology / University at Buffalo)
 
*Robert Arp (National Center for Biomedical Ontology / University at Buffalo)
 
*Elmer V. Bernstam (University of Texas Health Science Center at Houston)
 
*Elmer V. Bernstam (University of Texas Health Science Center at Houston)
*Olivier Bodenreider (Medical Ontology Research, National Library of Medicine / NIH)
 
 
*Bruce Bray (Dept of Biomedical Informatics, University of Utah)
 
*Bruce Bray (Dept of Biomedical Informatics, University of Utah)
 
*Anita Burgun (Université de Rennes)
 
*Anita Burgun (Université de Rennes)
Line 146: Line 150:
 
*David Karp (University of Texas Southwestern Medical Center at Dallas)
 
*David Karp (University of Texas Southwestern Medical Center at Dallas)
 
*Bron Kisler (CDISC)
 
*Bron Kisler (CDISC)
 +
*Megan Kong (University of Texas Southwestern Medical Center at Dallas)
 
*Suzanna Lewis (Lawrence Berkeley National Laboratory)
 
*Suzanna Lewis (Lawrence Berkeley National Laboratory)
 
*Daniele Merico (NEUROWEB / University of Toronto & University of Milano-Bicocca, DISCo)
 
*Daniele Merico (NEUROWEB / University of Toronto & University of Milano-Bicocca, DISCo)
 
*Pradeep Mutalik (Yale Center for Medical Informatics)
 
*Pradeep Mutalik (Yale Center for Medical Informatics)
*Meredith L. Nahm (Duke Translational Medicine Institute)
 
 
*Chimezie Ogbuji (Cleveland Clinic Foundation)
 
*Chimezie Ogbuji (Cleveland Clinic Foundation)
*Christopher Pierce (Heart and Vascular Institute / Cleveland Clinic)
 
 
*John Quinn (Health Level 7, Inc. (HL7))
 
*John Quinn (Health Level 7, Inc. (HL7))
 
*Alan Ruttenberg (Science Commons / Neurocommons)
 
*Alan Ruttenberg (Science Commons / Neurocommons)
Line 160: Line 163:
 
*Kent A. Spackman (International Health Terminology Standards Development Organization)
 
*Kent A. Spackman (International Health Terminology Standards Development Organization)
 
*Larry Streepy (Cleveland Clinic Foundation)
 
*Larry Streepy (Cleveland Clinic Foundation)
*Nicole Washington (Lawrence Berkeley National Laboratory)
+
*Gary Walker (Quintiles)
 
*Ashley Xia (NIAID / NIH)
 
*Ashley Xia (NIAID / NIH)
 
*W. Jim Zheng (Biomedical Ontology Research Group / Medical University of South Carolina)
 
*W. Jim Zheng (Biomedical Ontology Research Group / Medical University of South Carolina)
Line 167: Line 170:
  
 
==Suggested Background Reading==
 
==Suggested Background Reading==
 +
 +
[http://ontology.buffalo.edu/medo/continua.pdf Continua in Biological Systems], Stefan Schulz and Ingvar Johansson, The Monist, 2007; 90(4), 499-522.
  
 
[http://nuke.neurowebkc.eu/LinkClick.aspx?fileticket=opFTkenwCz0%3D&tabid=66&mid=435 NEUROWEB Project]: From Clinically-Based Phenotypes to Genomics Integration
 
[http://nuke.neurowebkc.eu/LinkClick.aspx?fileticket=opFTkenwCz0%3D&tabid=66&mid=435 NEUROWEB Project]: From Clinically-Based Phenotypes to Genomics Integration
Line 180: Line 185:
 
[http://bmir.stanford.edu/file_asset/index.php/1338/BMIR-2008-1302.pdf Using an Integrated Ontology and Information Model for Querying and Reasoning about Phenotypes: The Case of Autism], Samson W. Tu, Lakshika Tennakoon, Martin O'Connor, Ravi Shankar, and Amar Das.
 
[http://bmir.stanford.edu/file_asset/index.php/1338/BMIR-2008-1302.pdf Using an Integrated Ontology and Information Model for Querying and Reasoning about Phenotypes: The Case of Autism], Samson W. Tu, Lakshika Tennakoon, Martin O'Connor, Ravi Shankar, and Amar Das.
  
[http://ontology.buffalo.edu/medo/Williams_Disease.pdf The Factory Model of Disease], Neil Williams.
+
[http://ontology.buffalo.edu/medo/Williams_Disease.pdf The Factory Model of Disease], Neil Williams, The Monist, 2007; 90(4): 555-584.
 +
 
 +
[http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1948102 Human disease classification in the postgenomic era], J. Loscalzo, I. Kohane and A.-L. Barabasi
  
 
==Useful Links==
 
==Useful Links==
Line 192: Line 199:
 
[http://www.bioontology.org/wiki/index.php/PATO:Main_Page Phenotypic Quality Ontology]
 
[http://www.bioontology.org/wiki/index.php/PATO:Main_Page Phenotypic Quality Ontology]
  
==[[Proposed Terms]]==
+
==Proposed Terms and Definitions==
 +
 
 +
* [[Clinical Phenotypes | Toward an Ontological Treatment of the Initiation, Realization, Recognition, and Representation of Disease]]
 +
 
 +
==Follow-Up Meeting 2009==
 +
 
 +
[http://bimib.disco.unimib.it/index.php/SSFW09 Signs, Symptoms and Findings: Towards an Ontology for Clinical Phenotypes]

Latest revision as of 07:44, 7 April 2009

Signs, Symptoms and Findings: First Steps Toward an Ontology of Clinical Phenotypes

Workshop organized by:

Richard Scheuermann, University of Texas Southwestern Medical Center, Dallas

Barry Smith, National Center for Biomedical Ontology / University at Buffalo


Sponsored by:

University of Texas Southwestern Medical Center Clinical and Translational Science Award (CTSA) Program

National Center for Biomedical Ontology (NCBO)

Lead Horse Technologies, Inc.


Date:

September 3-4, 2008


Venue:

Dallas/Fort Worth Airport Marriott [1].

  • To take advantage of discounted rate at the conference hotel, guest room reservations must be secured no later than August 15. See Workshop registration form for further details.
  • There is no participation fee. Continental breakfast and refreshments will be provided to all registered participants at no cost.

This workshop is funded by the United States National Institutes of Health (NIH) through the NIH Roadmap for Medical Research, Grant 1 U54 HG004028, with support from the Clinical and Translational Science Award (1 U54 RR023468) and the Bioinformatics Integration Support Contract (1 N01 AI40076).

Information on the National Centers for Biomedical Computing can be found at: [2].

Overview

The aims of clinical and translational research are to achieve a better understanding of the pathogenesis of human disease in order to develop effective diagnostic, therapeutic and prevention strategies. Biomedical informatics can play an important role in supporting this research by facilitating the management, integration, analysis and exchange of data derived from and related to the research problems being studied. A key aspect of this support is to bring clarity, rigor and formalism to the representation of

1. disease initiation, progression, pathogenesis, signs, symptoms, assessments, clinical and laboratory findings, disease diagnosis, treatment, treatment response and outcome, and
2. the interrelations between these distinct entities both in patient management and in clinical research,

thus allowing the data to be more readily retrievable and shareable, and more able to serve in the support of algorithmic reasoning.

Goals

The goals of the workshop are:

  • to utilize consistent ontological design and development principles to describe disease signs and symptoms, clinical and laboratory findings, and their interrelations.
  • to delineate the roles that signs, symptoms and findings play in both clinical patient management and in clinical research.
  • to develop a clear understanding and representation of the distinction between clinical and pre-clinical manifestations of signs, symptoms and findings.
  • to take first steps towards harmonizing the ontological representation of disease signs and symptoms and clinical and laboratory findings with existing and emerging standards in knowledge representation from the health informatics and bioinformatics communities
  • to explore incorporation of the results of this work into the CTSA Human Studies Metadata Repository framework

Agenda

Day 1: Wednesday, September 3 (Room: Irving I-III, Lobby Level)

8:30am - Registration and Continental Breakfast

9:00am - Opening remarks / Workshop goals (Richard Scheuermann)

9:15am - Session 1: Signs, symptoms and laboratory findings from a health care perspective (Scheuermann, moderator)

Combining clinical exam and laboratory findings in the rheumatology clinic slides (David Karp)
Clinical signs and findings in neonatology slides (Andrew James)

10:30am - Refreshment Break

10:45am - Session 2: Ontology approaches to describing the clinical phenotype slides (Smith, moderator)

Reasoning with clinical exam and laboratory findings: The case of myocardial infarction slides (Sivaram Arabandi)

12:00pm - Buffet Lunch (Arlington Room, Lower Level), Provided by the generous support of Lead Horse Technologies, Inc.

1:00pm - Session 3: Standardization of clinical and laboratory data in the context of clinical and translational research (Jaffe, moderator)

Data standards from patient care to clinical and translational research: The CTSA perspective slides (Chris Chute)
Representation of clinical and laboratory findings in the CDISC SDTM slides (Bron Kisler and Gary Walker)

3:00pm - Refreshment Break

3:30pm - Session 3 continued (Ruttenberg, moderator)

The future of SNOMED-CT in the representation of clinical findings slides (Kent Spackman)
Problems with current approaches to clinical data slides (William Hogan)

5:30pm - Reception (Grand Prairie Room, Lower Level), Provided by the generous support of The Cleveland Clinic Foundation SemanticDB


Day 2: Thursday, September 4 (Room: Irving I-III, Lobby Level)

8:30am - Continental Breakfast

9:00am - Session 4: Proposals for unification of standard terminologies for the representation ‘sign’, ‘symptom’, ‘finding’ and related terms (Lewis, moderator)

Laboratory data and metadata in laboratory information systems slides (Anita Burgun)
An ontology-based approach for connecting disease pathogenesis with clinical/laboratory data slides (Richard Scheuermann)

10:30am - Refreshment Break

10:45am - Session 5: How consistent ontological design and development principles can lead to enhanced representation of signs, symptoms, and clinical and laboratory finding (Smith, moderator)

PATO and Phenote: From model organism phenotypes to clinical medicine slides (Suzanna Lewis)

12:00pm - Lunch Break

1:00pm - Session 6: Strategies to achieve convergence of ontologies, vocabularies and data structures in representing signs, symptoms, and clinical and laboratory findings (Scheuermann, moderator)

2:30pm - Refreshment Break

2:45pm - Session 6 (continued)

4:00pm - Close

Summary of Workshop

Participants

Error creating thumbnail: /srv/www/vhosts/www.bioontology.org/app/mediawiki-1.35.9/includes/shell/limit.sh: line 61: ulimit: cpu time: cannot modify limit: Permission denied /srv/www/vhosts/www.bioontology.org/app/mediawiki-1.35.9/includes/shell/limit.sh: line 84: ulimit: virtual memory: cannot modify limit: Permission denied /srv/www/vhosts/www.bioontology.org/app/mediawiki-1.35.9/includes/shell/limit.sh: line 90: ulimit: file size: cannot modify limit: Permission denied /bin/bash: /usr/bin/convert: No such file or directory Error code: 127
  • Jonas Silva Almeida (MD Anderson Cancer Center / University of Texas)
  • Sivaram Arabandi (Heart & Vascular Institute / Cleveland Clinic)
  • John M. Armstrong (Lead Horse Technologies, Inc.)
  • Robert Arp (National Center for Biomedical Ontology / University at Buffalo)
  • Elmer V. Bernstam (University of Texas Health Science Center at Houston)
  • Bruce Bray (Dept of Biomedical Informatics, University of Utah)
  • Anita Burgun (Université de Rennes)
  • Kei-Hoi Cheung (Senselab / Yale Center for Medical Informatics)
  • Christopher G. Chute (National Center for Biomedical Ontology / Mayo Clinic)
  • Paolo Ciccarese (Mass General Hospital / Harvard Medical School)
  • Timothy W. Clark (Mass General Institute for Neurodegenerative Disease / Harvard Medical School)
  • Gianluca Colombo (University of Milano-Bicocca, DISCo)
  • Tommie G. Curtis (SAIC, NCICB Contractor)
  • Amar K. Das (Center for Biomedical Informatics Research / Stanford University)
  • Louis J. Goldberg (Ontology Research Group / University at Buffalo)
  • Herb Hagler (University of Texas Southwestern Medical Center at Dallas)
  • William Hogan (University of Pittsburgh Medical Center)
  • Zhang-Zhi Hu (PRO / Georgetown University Medical Center)
  • Charles Jaffe (Health Level 7, Inc. (HL7))
  • Andrew G. James (Division of Neonatology, The Hospital for Sick Children / University of Toronto)
  • David Karp (University of Texas Southwestern Medical Center at Dallas)
  • Bron Kisler (CDISC)
  • Megan Kong (University of Texas Southwestern Medical Center at Dallas)
  • Suzanna Lewis (Lawrence Berkeley National Laboratory)
  • Daniele Merico (NEUROWEB / University of Toronto & University of Milano-Bicocca, DISCo)
  • Pradeep Mutalik (Yale Center for Medical Informatics)
  • Chimezie Ogbuji (Cleveland Clinic Foundation)
  • John Quinn (Health Level 7, Inc. (HL7))
  • Alan Ruttenberg (Science Commons / Neurocommons)
  • Neil Sarkar (Marine Biological Laboratory)
  • Richard Scheuermann (University of Texas Southwestern Medical Center at Dallas)
  • Lynn M. Schriml (Institute for Genome Sciences, University of Maryland)
  • Barry Smith (National Center for Biomedical Ontology / University at Buffalo)
  • Kent A. Spackman (International Health Terminology Standards Development Organization)
  • Larry Streepy (Cleveland Clinic Foundation)
  • Gary Walker (Quintiles)
  • Ashley Xia (NIAID / NIH)
  • W. Jim Zheng (Biomedical Ontology Research Group / Medical University of South Carolina)

In addition to NCBO and the University of Texas Southwestern Medical Center, the following communities are represented: CTSA, HL7, CDISC, OBO, SNOMED, and the NIH.

Suggested Background Reading

Continua in Biological Systems, Stefan Schulz and Ingvar Johansson, The Monist, 2007; 90(4), 499-522.

NEUROWEB Project: From Clinically-Based Phenotypes to Genomics Integration

OBO Foundry: Coordinated Evolution of Ontologies to Support Biomedical Data Integration

Ontology-Guided Data Preparation for Discovering Genotype-Phenotype Relationships

PhenomicDB: A New Cross-Species Genotype/Phenotype Resource

What is a Diagnosis?, Werner Ceusters

Using an Integrated Ontology and Information Model for Querying and Reasoning about Phenotypes: The Case of Autism, Samson W. Tu, Lakshika Tennakoon, Martin O'Connor, Ravi Shankar, and Amar Das.

The Factory Model of Disease, Neil Williams, The Monist, 2007; 90(4): 555-584.

Human disease classification in the postgenomic era, J. Loscalzo, I. Kohane and A.-L. Barabasi

Useful Links

Mammalian Phenotype Ontology

NCBO Bioportal

OBO Foundry

Phenotypic Quality Ontology

Proposed Terms and Definitions

Follow-Up Meeting 2009

Signs, Symptoms and Findings: Towards an Ontology for Clinical Phenotypes